| scholarly article | Q13442814 |
| P2093 | author name string | Enker WE | |
| Thaler HT | |||
| Cranor ML | |||
| Polyak T | |||
| P433 | issue | 4 | |
| P304 | page(s) | 335-346 | |
| P577 | publication date | 1995-10-01 | |
| P1433 | published in | Journal of the American College of Surgeons | Q15723630 |
| P1476 | title | Total mesorectal excision in the operative treatment of carcinoma of the rectum | |
| P478 | volume | 181 |
| Q35687617 | A new laparoscopic surgical procedure to achieve sufficient mesorectal excision in upper rectal cancer. |
| Q36609922 | A phase I/II study of irinotecan when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group Study |
| Q36615549 | A phase I/II study of oxaliplatin when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group (CCOG) study |
| Q79467677 | A prospective pathologic analysis using whole-mount sections of rectal cancer following preoperative combined modality therapy: implications for sphincter preservation |
| Q49215106 | A study into methodology and application of quantification of tumour vasculature in rectal cancer |
| Q55427621 | Advances in the management of rectal cancer. |
| Q53079229 | Altmetric Versus Bibliometric Perspective Regarding Publication Impact and Force. |
| Q33607161 | Anatomic basis of sharp pelvic dissection for curative resection of rectal cancer |
| Q24540128 | Anterior resection for rectal cancer with mesorectal excision: a prospective evaluation of 622 patients |
| Q36648303 | Anterior resection for rectal cancer with mesorectal excision: institutional review |
| Q37199353 | Assessment of the prognostic factors for a local recurrence of rectal cancer: the utility of preoperative MR imaging |
| Q36822349 | Cadaveric dissection for the rectal surgeon |
| Q36822151 | Challenging the feasibility and clinical significance of current guidelines on lymph node examination in rectal cancer in the era of neoadjuvant therapy |
| Q36772441 | Changes in disease pattern and treatment outcome of colorectal cancer: a review of 5,474 cases in 20 years |
| Q84879134 | Changes in treatment of rectal cancer: increased use of low anterior resection |
| Q37353934 | Chemoradiotherapy and adjuvant chemotherapy for rectal cancer |
| Q36463927 | Circumferential resection margin involvement in stage III rectal cancer patients treated with curative resection followed by chemoradiotherapy: a surrogate marker for local recurrence? |
| Q82663384 | Clinical Characteristics of Rectal Cancer Involving the Anal Canal |
| Q33794082 | Clinical and pathologic factors that predict lymph node yield from surgical specimens in colorectal cancer: a population-based study |
| Q45219204 | Clinical implication of additional selective lateral lymph node excision in patients with locally advanced rectal cancer who underwent preoperative chemoradiotherapy |
| Q51192406 | Comparative analysis of late functional outcome following preoperative radiation therapy or chemoradiotherapy and surgery or surgery alone in rectal cancer. |
| Q59328869 | Comparative survival analysis of preoperative and postoperative radiotherapy in stage II-III rectal cancer on the basis of long-term population data |
| Q39245319 | Comparison of short-term and oncologic outcomes of robotic and laparoscopic resection for mid- and distal rectal cancer. |
| Q51740262 | Determining therapeutic approaches in the elderly with rectal cancer. |
| Q62128616 | Distal clearance margin of 1 cm or less: a safe distance in lower rectum cancer surgery |
| Q38173327 | Distal dissection in total mesorectal excision, and preoperative chemoradiotherapy and lateral lymph node dissection for rectal cancer |
| Q83821349 | Effects of postoperative adjuvant radiotherapy on recurrence and survival in stage III rectal cancer |
| Q36423787 | Endoscopically observable white nodule caused by distal intramural lymphatic spread of rectal cancer: a case report |
| Q37210172 | Evolving management of colorectal cancer |
| Q34028010 | Evolving rectal cancer management in British Columbia. |
| Q37878381 | Extended abdominoperineal excision vs. standard abdominoperineal excision in rectal cancer--a systematic overview |
| Q39505416 | Extralevator abdominoperineal excision (Elape): A retrospective cohort study |
| Q38050970 | High ligation of the inferior mesenteric artery in rectal cancer surgery |
| Q58877878 | Hospital procedure volume and teaching status do not influence treatment and outcome measures of rectal cancer surgery in a large general population |
| Q35023082 | Identification of locally advanced rectal cancer with low risk of local recurrence |
| Q34112250 | Immunoscintigraphy of local recurrent rectal cancer with 99mTc-labeled anti-CEA monoclonal antibody CL58. |
| Q89502186 | Impact of Adjuvant Therapy Type on Survival in Stage II/III Rectal Cancer Without Preoperative Chemoradiation: A Korean Multicenter Retrospective Study |
| Q39974486 | Impact of Lateral Pelvic Lymph Node Dissection on the Survival of Patients with T3 and T4 Low Rectal Cancer. |
| Q40142774 | Impact of Recurrence and Salvage Surgery on Survival After Multidisciplinary Treatment of Rectal Cancer. |
| Q43326520 | Impact of lateral pelvic lymph node dissection on evacuatory and urinary functions following low anterior resection for advanced rectal carcinoma |
| Q36517467 | Improved access and visibility during stapling of the ultra-low rectum: a comparative human cadaver study between two curved staplers |
| Q34469631 | In the era of total mesorectal excision: adjuvant radiotherapy may be unnecessary for pT3N0 rectal cancer |
| Q36403045 | Initial clinical experience with robotic lateral pelvic lymph node dissection for advanced rectal cancer |
| Q34391337 | Is laparoscopic colorectal cancer surgery equal to open surgery? An evidence based perspective |
| Q44979668 | Isolated tumor cell in lateral lymph node has no influences on the prognosis of rectal cancer patients |
| Q36300533 | Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer |
| Q37946252 | Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer. |
| Q36324953 | Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer. |
| Q92776508 | Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer |
| Q54376724 | Lack of prognostic role of pre- and postoperative peritoneal cytology and cytokeratin PCR-expression on local recurrence after curative anterior resection for mid-low rectal cancer. |
| Q41971853 | Laparoscopic Procedures for Colon and Rectal Cancer Surgery |
| Q48689892 | Laparoscopic anterior resection and total mesorectal excision for rectal cancer: a prospective nonrandomized study. |
| Q42670566 | Laparoscopic rectal resection with anal sphincter preservation for rectal cancer: long-term outcome |
| Q46177940 | Laparoscopic resection of extraperitoneal rectal cancer: a comparative analysis with open resection. |
| Q89463418 | Laparoscopic surgery for rectal cancer: the verdict is not final yet! |
| Q34611899 | Laparoscopic total mesorectal excision |
| Q35614048 | Laparoscopic total mesorectal excision (TME) for rectal cancer surgery: long-term outcomes |
| Q42638522 | Laparoscopic total mesorectal excision for extraperitoneal rectal cancer: long-term results of a 18-year single-centre experience. |
| Q42695780 | Laparoscopic total mesorectal excision: a consecutive series of 100 patients |
| Q61866770 | Laparoscopic versus open surgery for extraperitoneal rectal cancer: a prospective comparative study |
| Q34791991 | Local excision after preoperative chemoradiation results in an equivalent outcome to total mesorectal excision in selected patients with T3 rectal cancer |
| Q64964423 | Local excision of T2 and T3 rectal cancers after downstaging chemoradiation. |
| Q81489210 | Local recurrence after laparoscopic resection of T3 rectal cancer without preoperative chemoradiation and a risk group analysis: an Asian collaborative study |
| Q53867526 | Local recurrence and survival after laparoscopic mesorectal resection forrectal adenocarcinoma. |
| Q80551553 | Local recurrence of rectal cancer after total mesorectal excision without preoperative radiotherapy |
| Q51220009 | Long-term functional outcome of colonic J-pouch reconstruction after low anterior resection for rectal cancer. |
| Q45017990 | Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer |
| Q35703248 | Management of rectal cancer |
| Q36097091 | Management of stage II/III rectal cancer |
| Q35855506 | Management of the pelvic recurrence of rectal cancer with radiofrequency thermoablation: a case report and review of the literature |
| Q33868392 | Modern management of rectal cancer: a 2006 update |
| Q40285447 | More extensive nodal dissection improves survival for stages I to III of colon cancer: a population-based study |
| Q45172873 | Multidisciplinary management of colorectal cancer enhances access to multimodal therapy and compliance with National Comprehensive Cancer Network (NCCN) guidelines |
| Q88761265 | Neoadjuvant oxaliplatin and capecitabine combined with bevacizumab plus radiotherapy for locally advanced rectal cancer: results of a single-institute phase II study |
| Q38546385 | Neoadjuvant treatment for locally advanced rectal cancer: a systematic review |
| Q46329607 | Nerve-oriented mesorectal excision (NOME): autonomic nerves as landmarks for laparoscopic rectal resection |
| Q43579125 | Oncologically safe distal resection margins in rectal cancer patients treated with chemoradiotherapy |
| Q88062740 | Outcome of bowel function following anterior resection for rectal cancer-an analysis using the low anterior resection syndrome (LARS) score |
| Q41020729 | Outcomes in 132 patients following laparoscopic total mesorectal excision (TME) for rectal cancer with greater than 5-year follow-up |
| Q90346335 | Patterns of care and outcomes for adjuvant treatment of pT3N0 rectal cancer using the National Cancer Database |
| Q34771979 | Patterns of local recurrence in rectal cancer after a multidisciplinary approach |
| Q36370711 | Patterns of recurrence following liver resection for colorectal metastases: effect of primary rectal tumor site |
| Q36621562 | Phase 1 dose de-escalation trial of the endogenous folate [6R]-5,10-methylene tetrahydrofolate in combination with fixed-dose pemetrexed as neoadjuvant therapy in patients with resectable rectal cancer |
| Q87477441 | Phase I trial of neoadjuvant preoperative chemotherapy with S-1, oxaliplatin, and bevacizumab plus radiation in patients with locally advanced rectal cancer |
| Q35128016 | Phase II study of preoperative bevacizumab, capecitabine and radiotherapy for resectable locally-advanced rectal cancer. |
| Q24201072 | Postoperative adjuvant chemotherapy in rectal cancer operated for cure |
| Q79467673 | Potential prognostic benefit of lateral pelvic node dissection for rectal cancer located below the peritoneal reflection |
| Q34224825 | Predicting prognosis of rectal cancer patients with total mesorectal excision using molecular markers |
| Q53074176 | Prediction of lateral pelvic lymph node metastasis in patients with locally advanced rectal cancer with preoperative chemoradiotherapy: Focus on MR imaging findings. |
| Q37475705 | Preoperative chemoradiotherapy does not necessarily reduce lymph node retrieval in rectal cancer specimens--results from a prospective evaluation with extensive pathological work-up. |
| Q36087573 | Preoperative chemoradiotherapy with capecitabine and oxaliplatin in locally advanced rectal cancer. A phase I-II multicenter study of the Dutch Colorectal Cancer Group |
| Q47309268 | Preoperative parameters expanding the indication of sphincter preserving surgery in patients with advanced low rectal cancer |
| Q34337068 | Prognostic determinants of patients with lateral nodal involvement by rectal cancer |
| Q53208805 | Prognostic significance of a preoperative magnetic resonance imaging assessment of the distance of mesorectal extension in clinical T3 lower rectal cancer. |
| Q34202487 | Prognostic significance of depth of gross or microscopic perirectal fat invasion in T3 N0 M0 rectal cancers following sharp mesorectal excision and no adjuvant therapy |
| Q83602432 | Prognostic significance of lateral lymph node dissection in node positive low rectal carcinoma |
| Q41786817 | Prognostic significance of the lymph node ratio regarding recurrence and survival in rectal cancer patients treated with postoperative chemoradiotherapy |
| Q53194126 | Prospective evaluation of sexual function after open and laparoscopic surgery for rectal cancer. |
| Q58793479 | Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2 + CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol |
| Q35331798 | Proximal and distal rectal cancers differ in curative resectability and local recurrence |
| Q36254599 | Proximal segmentation of the dorsal mesogastrium reveals new anatomical implications for laparoscopic surgery |
| Q48170996 | Quality of life and fecal incontinence after transanal endoscopic microsurgery for benign and malignant rectal lesions |
| Q43363260 | Quality-of-life impairment after endoluminal locoregional resection and laparoscopic total mesorectal excision |
| Q47100616 | Radiotherapy for stage IIA rectal cancer may not benefit all. |
| Q34522049 | Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery |
| Q77425371 | Recent advances in the treatment and outcome of locally advanced rectal cancer |
| Q36349876 | Rectal adenocarcinoma: proposal for a model based on pretreatment prognostic factors |
| Q37467198 | Rectal cancer in Kashmir: Early steps in the right direction |
| Q42597852 | Results of a multicenter study of 1,057 cases of rectal cancer treated by laparoscopic surgery |
| Q53301939 | Risk factors for symptomatic anastomotic leakage after low anterior resection for rectal cancer with 30 Gy/10 f/2 w preoperative radiotherapy. |
| Q37358226 | Robotic colorectal surgery |
| Q51891651 | Robotic surgery for rectal cancer: may it improve also survival? |
| Q50859127 | Robotic total mesorectal excision for rectal cancer using four robotic arms. |
| Q51888831 | Robotic total mesorectal excision for rectal cancer: it may improve survival as well as quality of life. |
| Q51893082 | Robotic tumor-specific mesorectal excision of rectal cancer: short-term outcome of a pilot randomized trial. |
| Q73086235 | Safety and efficacy of low anterior resection for rectal cancer: 681 consecutive cases from a specialty service |
| Q79736877 | Short- and midterm outcomes of laparoscopic surgery compared for 131 patients with rectal and rectosigmoid cancer |
| Q90673907 | Spectrophotometric assessment of bowel perfusion during low anterior resection: a prospective study |
| Q36084304 | Sphincter-preserving surgery after preoperative radiochemotherapy for T3 low rectal cancers |
| Q37462281 | Sphincter-sparing resection for rectal cancer |
| Q37072492 | Stratification of rectal cancer stage for selection of postoperative chemoradiotherapy: current status. |
| Q40956629 | Surgical Results and Oncologic Outcomes for Rectal Cancer with Tailored Mesorectal Excision over Two Decades. |
| Q61649343 | Surgical Treatment of Adenocarcinoma of the Rectum |
| Q79249835 | Surgical quality assurance in breast, gastric and rectal cancer |
| Q37234914 | Surgical treatment for locally advanced lower third rectal cancer after neoadjuvent chemoradiation with capecitabine: prospective phase II trial |
| Q50740939 | Survival benefit of lateral lymph node dissection according to the region of involvement and the number of lateral lymph nodes involved. |
| Q35011194 | Survival benefits and trends in use of adjuvant therapy among elderly stage II and III rectal cancer patients in the general population |
| Q73164021 | T3N0 rectal cancer: results following sharp mesorectal excision and no adjuvant therapy |
| Q33320075 | The Quality Initiative in Rectal Cancer (QIRC) trial: study protocol of a cluster randomized controlled trial in surgery |
| Q98564377 | The feasibility of laparoscopic TSME preserving the left colic artery and superior rectal artery for upper rectal cancer |
| Q44032086 | The impact of shortened postgraduate surgical training on colorectal cancer outcome |
| Q36316112 | The implications of an incidental chronic lymphocytic leukaemia in a resection specimen for colorectal adenocarcinoma |
| Q37462225 | The pathologist's role in rectal cancer patient assessments |
| Q36537071 | The role of postoperative pelvic radiation in stage IV rectal cancer after resection of primary tumor |
| Q37462219 | Total mesorectal excision: what are we doing? |
| Q87884153 | Total number of lymph node metastases is a more significant risk factor for poor prognosis than positive lateral lymph node metastasis |
| Q30883626 | Training and quality assurance for rectal cancer: 20 years of data is enough |
| Q90169923 | Transanal versus laparoscopic total mesorectal excision for mid and low rectal cancer: a meta-analysis of short-term outcomes |
| Q33608042 | Trends with neoadjuvant radiotherapy and clinical staging for those with rectal malignancies |
| Q61447827 | Tumor location as an indication for adjuvant radiotherapy in pT3N0 rectal cancer after surgery |
| Q55019425 | Tumor location is an independent predictive factor for distant metastasis and metastatic sites of rectal adenocarcinoma in patients receiving total mesorectal excision. |
| Q46856494 | Tumor response to neoadjuvant chemoradiation in rectal cancer: predictor for surgical morbidity? |
| Q46932724 | Urinary and sexual disorders after laparoscopic TME for rectal cancer in males. |
| Q89513951 | What is the advantage of rectal amputation with an initial perineal approach for primary anorectal carcinoma? |
| Q79268944 | [Surgical therapy of rectal carcinoma] |
Search more.